Medication info

Farjagliflozin 10 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin›10mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
Yellow, bilaterally convex, diamond-shaped film-coated tablet
Packaging
Bottle pack - 100 tablets/bottle, PTP pack - 8 tablets/PTP
Approval status
Expired

MFDS item code 202004455 · Approved 2020.06.17

This product's status changed to Expired on 2025.06.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can also be administered as monotherapy, and in cases where blood sugar control is difficult, it can be combined with medications such as metformin, sulfonylureas, insulin, or sitagliptin. Such combination therapy is applicable when sufficient blood sugar control has not been achieved with various diabetes drug therapies. Therefore, this medication is used to effectively assist in blood sugar management for patients with type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used by patients who are allergic to the active ingredient or excipients. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. Patients with genetic lactose intolerance should not use this medication due to the anhydrous lactose contained in it. Patients undergoing renal dialysis should also not take this medication. Patients with decreased fluid volume or renal function problems should use this medication with caution. This medication can lower blood pressure and may pose a risk of rapid deterioration of renal function; therefore, fluid status and renal function should be closely monitored before and after administration. In particular, patients with moderate to severe impairment of renal function may experience reduced efficacy for blood sugar control. Common side effects while taking this medication include genital infections, which occur more frequently in women. Other reported side effects include urinary tract infection, hypoglycemia, reduced fluid volume, dizziness, dry mouth, constipation, and back pain, among others. A serious metabolic abnormality known as diabetic ketoacidosis may occur, and if symptoms such as vomiting, abdominal pain, or difficulty breathing appear, immediate consultation with medical personnel is required. While this medication helps control blood sugar, it may increase the risk of hypoglycemia when taken with medications such as insulin or sulfonylureas. Therefore, dosage adjustments may be necessary. Women who are pregnant or breastfeeding should not use this medication, and if pregnancy is confirmed, they should stop taking it immediately. Elderly patients or those with impaired renal function are at higher risk of side effects and should be monitored closely, with regular renal function tests recommended. This medication may cause positive results in urinary glucose tests; therefore, it is advisable to use other tests when assessing blood sugar control. In the event of an overdose, there are no specific antidotes; treatment should be symptomatic, and proper measures should be taken according to medical personnel's instructions if required. During the use of this medication, fluid status should be carefully managed, and symptoms of infection or hypoglycemia should be monitored, with immediate consultation with a physician if abnormalities occur.

Side effects

  • Vulvovaginitis
  • balanitis
  • genital infections
  • urinary tract infections
  • fungal infections
  • perineal necrosis
  • hypoglycemia
  • decreased fluid volume
  • thirst
  • diabetic ketoacidosis
Show 88 more
  • dizziness
  • constipation
  • dry mouth
  • lumbar pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar itching
  • genital itching
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • elevated blood creatinine
  • elevated blood urea
  • weight loss
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • rash
  • angioedema
  • asthenia
  • pain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral arterial occlusion
  • angina
  • myocardial infarction
  • bile duct stones
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • acute pyelonephritis
  • chest pain
  • taste disturbance
  • drowsiness
  • tension-type headache
  • carpal tunnel syndrome
  • diabetic neuropathy
  • unconsciousness
  • nerve compression
  • neuralgia
  • peripheral neuropathy
  • sleep disorders
  • syncope
  • tremor
  • herpes simplex
  • edema
  • fever
  • foreign body sensation
  • facial edema
  • facial pain
  • warmth
  • influenza-like syndrome
  • chest discomfort
  • genital rash
  • menorrhagia
  • genital edema
  • uterine bleeding
  • vaginal bleeding
  • vulvar discomfort
  • irregular menstruation
  • itching
  • urticaria
  • cold sweat
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyp
  • tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity, so it should be stored in a tightly closed container. Additionally, it is advisable to avoid extremely hot or cold places, and to store it at a temperature between 1°C and 30°C, which is at room temperature.

Appearance and packaging

Appearance

Yellow, bilaterally convex, diamond-shaped film-coated tablet

Package unit

Bottle pack - 100 tablets/bottle, PTP pack - 8 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.